Leflunomide in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT02509052 · COMPLETED
Trial details
- NCT number
- NCT02509052
- Sponsor
- City of Hope Medical Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-02
- Primary completion
- 2018-09-18
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.